Data / Form D filings / Exactics, Inc.
Exactics, Inc.: Form D filing
Exactics, Inc., a biotechnology company in Chicago, IL, filed a Form D with the SEC in 2026. The latest, on June 25, 2026, reports $855,000 sold of a $1.5 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 5207 S. HARPER AVENUE, Chicago, IL, 60615
- Phone
- (331) 232-6000
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2136792
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 25, 2026 | New notice | $1,500,000 | $855,000 | $645,000 | 11 | Apr 13, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JULIAN KAGE | Executive Officer, Director, Promoter |
Other biotechnology companies in Illinois that filed recently
- Neopenda, PBC $215,000 · Aug 27, 2026
- Auvi Labs, Inc. $442,352 · Aug 26, 2026
- Archean Sciences, Inc. $385,000 · Aug 13, 2026
Every Form D from the week of Jun 22, 2026 · All recent filings in Illinois · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Exactics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.